Xilio Therapeutics Inc. Common Stock (XLO)
Stock · NASDAQ · Health Care
$9as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$8.28
Industry
Biotechnology: Pharmaceutical Preparations
About XLO
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart,…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 76
- Website
- xiliotx.com/
Fundamentals
- 1-day range
- $9$9.4
- Market cap
- $60.95M
- P/E (trailing)
- —
- P/E (forward)
- -15.81
- EPS (trailing)
- $-3.51
- Dividend yield
- —
- Beta
- -0.11
- Avg. volume
- 48.0K
52-week range
$6.47$12.74
Forecasts
1 analyst ratings
Buy 80%
Hold 20%
Sell 0%
1-year price forecast
High
$20
+122.2%
Median
$20
+122.2%
Low
$20
+122.2%
Xilio Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- XLOXilio Therapeutics Inc. Common Stock$9▼ 0.22%Market cap $60.95MP/E —$6.47$12.74
- PMVPPMV Pharmaceuticals Inc. Common Stock$1.22▼ 1.61%Market cap $62.93MP/E —$1.02$1.88
- DWTXDogwood Therapeutics Inc. Common Stock$2.6▲ 12.07%Market cap $58.85MP/E —$1.28$9.5
- BOLDBoundless Bio Inc. Common Stock$2.83▼ 1.05%Market cap $63.80MP/E —$0.9612$3.16
- ANVSAnnovis Bio Inc. Common Stock$1.72▼ 4.97%Market cap $64.44MP/E —$1.54$5.5
- PLRXPliant Therapeutics Inc. Common Stock$1.11▼ 3.48%Market cap $65.02MP/E —$1.02$1.95
- IMMPImmutep Limited American Depositary Shares$0.3848▲ 1.26%Market cap $55.21MP/E —$0.028$0.47
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| XLO Xilio Therapeutics Inc. Common Stock | $60.95M | — | $9 | ▼ 0.22% | $6.47$12.74 |
| PMVP PMV Pharmaceuticals Inc. Common Stock | $62.93M | — | $1.22 | ▼ 1.61% | $1.02$1.88 |
| DWTX Dogwood Therapeutics Inc. Common Stock | $58.85M | — | $2.6 | ▲ 12.07% | $1.28$9.5 |
| BOLD Boundless Bio Inc. Common Stock | $63.80M | — | $2.83 | ▼ 1.05% | $0.9612$3.16 |
| ANVS Annovis Bio Inc. Common Stock | $64.44M | — | $1.72 | ▼ 4.97% | $1.54$5.5 |
| PLRX Pliant Therapeutics Inc. Common Stock | $65.02M | — | $1.11 | ▼ 3.48% | $1.02$1.95 |
| IMMP Immutep Limited American Depositary Shares | $55.21M | — | $0.3848 | ▲ 1.26% | $0.028$0.47 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →Acquired
50.0K
Disposed
0
- Curran Daniel J. · June 11, 2026 · Grant5.0K
- Bello Akintunde Olatokumbo · June 11, 2026 · Grant5.0K
- Xu Yuan · June 11, 2026 · Grant5.0K
- ROSS ROBERT W. · June 11, 2026 · Grant5.0K
- Aoife Brennan · June 11, 2026 · Grant5.0K
- Sara Bonstein · June 11, 2026 · Grant5.0K
- James Samuel Shannon · June 11, 2026 · Grant5.0K
- Blanchard Cheryl R · April 15, 2026 · Grant10.0K
- James Samuel Shannon · March 26, 2026 · Buy5.0K @ $8.79
Institutional Ownership
March 31, 2026
- Total shares held
- 1.94M
- Total value held
- $16.17M
- Institutional holders
- 20
Top holders this quarter
- Unknown664.0K
- Unknown422.5K
- Unknown152.5K
- Unknown123.7K
- Unknown112.1K
- Unknown106.0K
- Unknown64.2K
- Unknown57.5K
- Unknown49.6K
- Unknown47.7K
See the full, filterable feed with live charts on the MarketWall dashboard.